WuXi ATU Co., Ltd. (hereinafter referred to as “ATU”) was founded in September 2017 in Huishan Economic Development Zone, Wuxi City, It is a wholly owned subsidiary of WuXi AppTec (Shanghai) Co., Ltd. (hereinafter referred to as "WuXi AppTec"). It mainly engaged in cell therapy products, gene carrier research and development, production and other related services business. ATU will plan to build Shanghai R & D base, Wuxi R & D base and Wuxi GMP production base. Thereinto, Wuxi R&D base and production base is located in the Life Science and Technology Industrial Park of Huishan Economic Development Zone, with a total area of more than 13,000 square meters.
ATU will make full use of WuXi AppTec's Philadelphia-based technology and service experience in the area of cell gene therapy for more than ten years, and will build a one-stop service platform in China, which covering the whole process of production of gene cell therapy products and integrating research and development, production, product approval and consultation. ATU's services will include GMP production of gene vector plasmids, research and development of gene vectors and GMP production, as well as research and development of cell therapy products and GMP production.